-
-
-
-
-
-
-
Evolus (EOLS) Announces Positive Data from Pivotal Trial for First Two Evolysse Dermal Filler Products at 2024 SCALE Meeting
-
-
-
-
-
-
-
Arrowhead Pharmaceuticals (ARWR) Presents New Clinical Data Showing ARO-RAGE Achieves High Level of Gene Knockdown in Patients with Asthma
-
-
-
-
-
-
-
Azitra, Inc (AZTR) Presents Positive Preclinical Data from ATR-04
-
-
-
-
-
-
-
Agenus (AGEN) Granted FDA Type B End-of-Phase 2 Meeting for BOT/BAL Therapy
-
-
-
-
-
-
-
Kineta (KA) Reports Q1, Provides Update on Phase 1/2 VISTA-101 Trial
-
-
-
-
-
-
-
TFF Pharmaceuticals Inc. (TFFP) Provides Update on TFF TAC Phase 2 Trial
-
-
-
-
-
-
-
Neurocrine Biosciences (NBIX) Presented Baseline Data from the CAHtalyst Program in CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ECE 2024
-
67,102 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.